What's Happening?
New research from the University of Oklahoma has identified the body's stress response as a trigger for heart inflammation following a heart attack. The study, published in Nature Communications, reveals that neutrophils, a type of white blood cell, are
mobilized not from the bone marrow as previously thought, but from reserves along blood vessel walls. This rapid mobilization is triggered by stress hormones like norepinephrine, which signal the neutrophils to detach and travel to the heart, causing inflammation. The research, led by Prabha Nagareddy, Ph.D., suggests that controlling this response could improve heart healing. In experiments with mice, the use of beta two blockers reduced the harmful surge of neutrophils, leading to better heart recovery.
Why It's Important?
This discovery has significant implications for post-heart attack treatment. By understanding the role of stress hormones in heart inflammation, medical professionals can potentially improve recovery outcomes for heart attack patients. The use of beta blockers, already common in heart attack treatment, could be optimized to include non-selective beta blockers that target both beta one and beta two receptors. This approach could reduce the inflammatory response, allowing the heart to heal more effectively. The research highlights the importance of managing the body's stress response to prevent further damage and improve long-term heart health.
What's Next?
The next step for researchers is to test whether this approach can be applied to humans. If successful, it could lead to changes in standard post-heart attack treatment protocols, incorporating non-selective beta blockers to manage the stress-induced immune response. This could potentially reduce the risk of complications and improve recovery rates for heart attack patients. Further studies will be needed to confirm the efficacy and safety of this treatment in human subjects.
